Propanal is an aldehyde that consists of ethane bearing a formyl substituent.
定義
Propanal is an aldehyde that consists of ethane bearing a formyl substituent. The parent of the class of propanals. It has a role as an Escherichia coli metabolite. It is a member of propanals and an alpha-CH2-containing aldehyde.
出典: PubChem
米国FDA 物質登録 · UNII AMJ2B4M67V · 登録名 Propionaldehyde · 単一の化学物質
化粧品での役割
製品に香りをつけるPERFUMING
安全性・規制情報
韓国の有害物質GHS分類なし · 既存化学物質
詳しい資料 — 表示名・識別番号・物性・試験記録・文献
別名・識別情報
PROPIONALDEHYDEINCIPropanal別名
- CAS No.化学物質登録番号
- 123-38-6
- EC No.EU化学物質目録番号
- 204-623-0
- DTXSID米国EPA化学物質番号
- DTXSID2021658
- DTXCID米国EPA化合物番号
- DTXCID001658
- IUPAC
- Propanal
- 分子式
- C3H6O
- 分子量
- 58.08 g/mol
測定された物性
- 性状
- Propionaldehyde appears as a clear colorless liquid with an overpowering fruity-like odor. Less dense than water. Flash point 15 °F. Vapors are heavier than air. · Liquid
- 臭い
- SUFFOCATING, FRUITY · CHARACTERISTIC ODOR SIMILAR TO ACETALDEHYDE
- 沸点
- 120 °F at 760 mmHg (NTP, 1992) · 48 °C
- 融点
- -114 °F (NTP, 1992) · -80 °C
- 溶解性
- 50 to 100 mg/mL at 64 °F (NTP, 1992) · Soluble in water, miscible with ethanol, ethyl ether
- 密度
- 0.805 at 68 °F (USCG, 1999) - Less dense than water, will float · 0.8657 g/cu cm at 25 °C
- 粘度
- 0.3167 cP at 26.7 °C
- 色
- 無色
- 臭いの閾値
- 1 ppm
- 融点・凝固点
- -81 ℃
- 初留点および沸点範囲
- 49 ℃
- 引火点
- -30 ℃(c.c.)
- 燃焼・爆発範囲の上限/下限
- 17 / 2.6 %
- 蒸気圧
- 31.3 ㎪ (20℃)
- 溶解度
- 30.6 g/100㎖ (25℃)
- 蒸気密度
- 2
- 比重
- 0.8
- n-オクタノール/水分配係数（Kow）
- 0.59
- 自然発火温度
- 207 ℃
- 分子量
- 58.09
物質そのものを測定した値です。安全保健公団（KOSHA）の資料はSDS作成・確認の参考用で、原料商品の規格ではありません。
出典: PubChem · 韓国安全保健公団 SDS
製品が実際に使っている用途
米国EPAにこの成分を届け出た製品11件の用途です。化粧品以外の製品も含まれるため、上の数行がこの成分の主な使い道といえます。
- Fragrance4
- Flavouring and nutrient2
- Monomers2
- Intermediate2
- Chemical reaction regulator1
出典: 米国EPA CompTox
刺激・感作試験の記録
皮膚試験9件・眼試験6件の記録があります。
中程度と分類1件
試験の結論はおおむね一致しています（100%）。 原料そのものを試験した記録で、完成品に含まれる濃度での刺激性とは異なります。
試験15件をすべて見る
- Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) - Not likely to be sensitizing
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) - Skin corrosion/irritation - Category 2
Skin Irritation · Screening - Classification not possible
Skin Sensitization · Screening - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Category 2
Skin Irritation · Screening - Category 6.3B (Category 3)
Skin Irritation · Read Across - Skin Irrit. 2
Skin Irritation · Authoritative - Severe Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to - Corrosive or Irritation Persists for > 21 days
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Category 2
Eye Irritation · Screening - Category 6.4A (Category 2A)
Eye Irritation · Read Across - Serious eye damage/eye irritation - Category 2A
Eye Irritation · Screening - Eye Irrit. 2
Eye Irritation · Authoritative
出典: 米国EPA CompTox
関連文献
- Association of subjective health symptoms with Indoor Air Quality in European office buildings: The OFFICAIR project. · 2020
- Analysis of Volatile Compounds in Food and Cosmetic, Using the Purge and Trap Injector Coupled to a Gas Chromatograph with Photo Ionization Detector · 2010
- Preparation and Evaluation of Transdermal Drug Delivery System of Etoricoxib Using Modified Chitosan · 2008
- In vitro penetration and subchronic toxicity of alpha-methyl-1,3-benzodioxole-5-propionaldehyde. · 2007
- Transdermal delivery of antiasthmatic drug through modified chitosan membrane · 2005